Nektar Therapeutics (NKTR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Nektar Therapeutics

NASDAQ: NKTR · Real-Time Price · USD
58.50
2.88 (5.18%)
At close: Sep 26, 2025, 3:59 PM
58.10
-0.68%
After-hours: Sep 26, 2025, 07:54 PM EDT

Nektar Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
44.25M 35.28M 88.23M 25.22M
Short-Term Investments
210.97M 268.34M 416.75M 708.74M
Long-Term Investments
26.09M 25.82M n/a 64.83M
Other Long-Term Assets
4.65M 4.64M 2.25M 2.74M
Receivables
1.61M 2.25M 5.98M 22.49M
Inventory
n/a 16.1M 19.2M 15.8M
Other Current Assets
n/a n/a 2.42M n/a
Total Current Assets
261.29M 330.7M 545.97M 795.58M
Property-Plant & Equipment
11.82M 36.86M 85.89M 177.53M
Goodwill & Intangibles
n/a n/a 76.5M 76.5M
Total Long-Term Assets
42.56M 67.33M 164.63M 321.61M
Total Assets
303.85M 398.03M 710.6M 1.12B
Account Payables
11.56M 9.85M 12.98M 9.75M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a 19.26M 18.67M 17.44M
Other Current Liabilities
29.97M -2.65M 8.31M 24.84M
Total Current Liabilities
61.4M 51.27M 68.2M 85.2M
Long-Term Debt
91.78M 112.63M 126.47M 148.11M
Other Long-Term Liabilities
7.24M 4.63M 36.46M 78.63M
Total Long-Term Liabilities
181.71M 215.78M 275.76M 352.48M
Total Liabilities
243.11M 267.05M 343.96M 437.68M
Total Debt
102.56M 117.78M 131.5M 143.18M
Book Value
60.74M 130.99M 366.64M 679.51M
Book Value Per Share
4.43 10.34 29.39 55.61
Common Stock
19K 19K 19K 19K
Retained Earnings
-3.6B -3.48B -3.2B -2.83B
Comprehensive Income
61K 80K -6.91M -4.16M
Shareholders Equity
60.74M 130.99M 366.64M 679.51M
Total Investments
237.06M 294.16M 416.75M 773.57M